Night blindness

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Abstract

Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006 May;26(3):326-41. Abstract

Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008 May;19(3):255-62. Abstract

Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun. 1989 Jun 15;161(2):825-9. Abstract

1. Joshi D, Dhawan A, Baker AJ, et al. An atypical presentation of cystic fibrosis: a case report. J Med Case Reports. 2008 Jun 12;2:201.Full text  Abstract

2. Lee WB, Hamilton SM, Harris JD, et al. Ocular complications of hypovitaminosis A after bariatric surgery. Ophthalmology. 2005 Jun;112(6):1031-4. Abstract

3. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Abstract

4. Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006 May;26(3):326-41. Abstract

5. Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol. 2006 Jul-Sep;21(3):135-41. Abstract

6. Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008 May;19(3):255-62. Abstract

7. Ferrari S, Di Iorio E, Barbaro V, et al. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics. 2011 Jun;12(4):238-49.Full text  Abstract

8. Jayaram H, Downes SM. Midlife diagnosis of Refsum disease in siblings with retinitis pigmentosa--the footprint is the clue: a case report. J Med Case Reports. 2008 Mar 12;2:80.Full text  Abstract

9. Zeitz C, Robson AG, Audo I. Congenital stationary night blindness: an analysis and update of genotype-phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res. 2015 Mar;45:58-110.Full text  Abstract

10. World Health Organization. Xerophthalmia and night blindness for the assessment of clinical vitamin A deficiency in individuals and populations. 2014 [internet publication].Full text

11. McCauley ME, van den Broek N, Dou L, et al. Vitamin A supplementation during pregnancy for maternal and newborn outcomes. Cochrane Database Syst Rev. 2015 Oct 27;(10):CD008666.Full text  Abstract

12. Sommer A. Vitamin A deficiency and clinical disease: an historical overview. J Nutr. 2008 Oct;138(10):1835-9.Full text  Abstract

13. Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun. 1989 Jun 15;161(2):825-9. Abstract

14. Potter MJ, Thirkill CE, Dam OM, et al. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology. 1999 Nov;106(11):2121-5. Abstract

15. Javadzadeh A, Gharabaghi D. Gyrate atrophy of the choroid and retina with hyper-ornithinemia responsive to vitamin B6: a case report. J Med Case Reports. 2007 Jun 12;1:27.Full text  Abstract

16. Renner AB, Kellner U, Cropp E, et al. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology. 2006 Nov;113(11):2066.e1-10. Abstract

17. UK Government Office for Health Improvement and Disparities. Vitamin A: migrant health guide. Advice and guidance on the health needs of migrant patients for healthcare practitioners. May 2021 [internet publication].Full text

18. UK National Health Service. Vitamins and minerals: vitamins for children. April 2021 [internet publication].Full text

19. Radhika MS, Bhaskaram P, Balakrishna N, et al. Effects of Vitamin A deficiency during pregnancy on maternal and child health. BJOG. 2002 Jun;109(6):689-93. Abstract

20. Mayo-Wilson E, Imdad A, Herzer K, et al. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ. 2011 Aug 25;343:d5094.Full text  Abstract

21. Imdad A, Mayo-Wilson E, Haykal MR, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2022 Mar 16;3(3):CD008524.Full text  Abstract

22. UK National Health Service. Vitamins and minerals: vitamin A. August 2020 [internet publication].Full text

23. Alio JL, Pinero D, Muftuoglu O. Corneal wavefront-guided retreatments for significant night vision symptoms after myopic laser refractive surgery. Am J Ophthalmol. 2008 Jan;145(1):65-74. Abstract

24. Stone EM, Andorf JL, Whitmore SS, et al. Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease. Ophthalmology. 2017 Sep;124(9):1314-31.Full text  Abstract

25. Genead MA, Fishman GA, Lindeman M. Fundus white spots and acquired night blindness due to vitamin A deficiency. Doc Ophthalmol. 2009 Dec;119(3):229-33. Abstract

26. ​Byron LL (ed.) Electrophysiology of vision: clinical testing and applications. 1st ed. Boca Raton: CRC Press; 2005.

27. Yanoff M, Duker JS. Ophthalmology. 4th ed. Saunders; 2013.

28. Robson AG, Frishman LJ, Grigg J, et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol. 2022 Jun;144(3):165-77.Full text  Abstract

29. Tanumihardjo SA. Assessing vitamin A status: past, present and future. J Nutr. 2004 Jan;134(1):290S-293S.Full text  Abstract

30. Charman WN. Night myopia and driving. Ophthalmic Physiol Opt. 1996 Nov;16(6):474-85. Abstract

31. Owsley C, Jackson GR, White M, et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001 Jul;108(7):1196-202. Abstract

32. American Academy of Opthalmology. Pediatric eye evaluations: Preferred Practice Pattern. ​2022 [internet publication].Full text

33. American Academy of Opthalmology. Comprehensive adult medical eye evaluation: Preferred Practice Pattern. ​2020 [internet publication].Full text

34. American Academy of Opthalmology. Policy statement: frequency of ocular examinations. March 2015 [internet publication].Full text

35. Bastos Maia S, Rolland Souza AS, Costa Caminha MF, et al. Vitamin A and pregnancy: a narrative review. Nutrients. 2019 Mar 22;11(3):681.Full text  Abstract

36. Berson EL, Rosner B, Sandberg MA, et al. Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993 Nov;111(11):1456-9. Abstract

37. Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol. 2010 Apr;128(4):493-5. Abstract

38. Schwartz SG, Wang X, Chavis P, et al. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa. Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD008428.Full text  Abstract

39. Welsh BM, Smith AL, Elder JE, et al. Night blindness precipated by isotretinoin in the setting of hypovitaminosis A. Australas J Dermatol. 1999 Nov;40(4):208-10. Abstract

40. Russell S, Bennett J, Wellman JA, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017 Aug 26;390(10097):849-60.Full text  Abstract

41. Bainbridge JW, Mehat MS, Sundaram V, et al. Long-term effect of gene therapy on Leber's congenital amaurosis. N Engl J Med. 2015 May 4;372(20):1887-97.Full text  Abstract

42. Jacobson SG, Cideciyan AV, Roman AJ, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015 May 14;372(20):1920-6.Full text  Abstract

43. Bennett J, Wellman J, Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016 Aug 13;388(10045):661-72.Full text  Abstract

44. MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014 Mar 29;383(9923):1129-37.Full text  Abstract

45. Dimopoulos IS, Hoang SC, Radziwon A, et al. Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience. Am J Ophthalmol. 2018 Sep;193:130-42. Abstract

46. Cross N, van Steen C, Zegaoui Y, et al. Current and future treatment of retinitis pigmentosa. Clin Ophthalmol. 2022 Aug 31;16:2909-21.Full text  Abstract

47. Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol. 2004 Sep;122(9):1297-305. Abstract

48. Hoffman DR, Locke KG, Wheaton DH, et al. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol. 2004 Apr;137(4):704-18. Abstract

49. Berson EL, Rosner B, Sandberg MA, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol. 2004 Sep;122(9):1306-14. Abstract

50. Hoffman DR, Hughbanks-Wheaton DK, Pearson NS, et al. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial. JAMA Ophthalmol. 2014 Jul;132(7):866-73.Full text  Abstract

51. Jackson ML, Virgili G, Shepherd JD, et al. Vision rehabilitation preferred practice pattern®. Ophthalmology. 2023 Mar;130(3):P271-335.